Akèy › Kansè Poumon ki pa ti selil › Illinois › Waukegan
Etid klinik pou Kansè Poumon ki pa ti selil nan Waukegan, IL
16 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Waukegan (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi lwen
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- City of Hope Chicago, Zion · 6 mi lwen
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Ap rekriteFaz 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mi lwen
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mi lwen
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi lwen
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Ap rekriteFaz 3
- Research Site, Zion · 6 mi lwen
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Research Site, North Chicago · 3 mi lwen
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Ap rekriteFaz 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi lwen
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Ap rekriteFaz 3
- Cancer Treatment Centers of America (CTCA), Zion · 6 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
- ak 1 plis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
- ak 1 plis
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
- ak 1 plis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi lwen
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Ap rekriteFaz 2
- City of Hope at Chicago, Zion · 6 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Waukegan
- Kansè poumon16 etid
- Kansè nan tete12 etid
- Kolit Ulseratif7 etid
- Kansè renn (Kasinom selil renn)7 etid
- Kansè ovè6 etid
- Kansè Metastatik6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè kolorektal6 etid
- Kansè pwostat6 etid
- Melanom5 etid
- Leksemi mieloïd egi5 etid
- Maladi Crohn5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.